IS5763A - Samsetning sem inniheldur karnitín og inósitól fosfat gagnleg sem næringafræðilegt bætiefni eða lyf - Google Patents

Samsetning sem inniheldur karnitín og inósitól fosfat gagnleg sem næringafræðilegt bætiefni eða lyf

Info

Publication number: IS5763A
Authority: IS; Iceland
Prior art keywords: drug; composition containing; nutritional supplement; inositol phosphate; containing carnitine
Prior art date: 1999-04-22

Application number

IS5763A

Other languages

English (en)

Inventor

Cavazza Claudio

Original Assignee

Sigma-Tau Healthscience S.P.A.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-04-22

Filing date

2000-12-08

Publication date

2000-12-08

2000-12-08 Application filed by Sigma-Tau Healthscience S.P.A. filed Critical Sigma-Tau Healthscience S.P.A.

2000-12-08 Publication of IS5763A publication Critical patent/IS5763A/is

Links

PHIQHXFUZVPYII-ZCFIWIBFSA-O (R)-carnitinium Chemical compound C[N+](C)(C)C[C@H](O)CC(O)=O PHIQHXFUZVPYII-ZCFIWIBFSA-O 0.000 title 1
INAPMGSXUVUWAF-GCVPSNMTSA-N [(2r,3s,5r,6r)-2,3,4,5,6-pentahydroxycyclohexyl] dihydrogen phosphate Chemical compound OC1[C@H](O)[C@@H](O)C(OP(O)(O)=O)[C@H](O)[C@@H]1O INAPMGSXUVUWAF-GCVPSNMTSA-N 0.000 title 1
229960004203 carnitine Drugs 0.000 title 1
235000015872 dietary supplement Nutrition 0.000 title 1
229940079593 drug Drugs 0.000 title 1
239000003814 drug Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7024—Esters of saccharides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Molecular Biology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Neurology (AREA)
Biochemistry (AREA)
Orthopedic Medicine & Surgery (AREA)
Nutrition Science (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Physical Education & Sports Medicine (AREA)
Toxicology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Medicines Containing Plant Substances (AREA)
Medicinal Preparation (AREA)

IS5763A 1999-04-22 2000-12-08 Samsetning sem inniheldur karnitín og inósitól fosfat gagnleg sem næringafræðilegt bætiefni eða lyf IS5763A (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IT1999RM000248A IT1306133B1 (it)	1999-04-22	1999-04-22	Composizione comprendente una carnitina ed un inositolfosfato, utilequale integratore dietetico o medicamento.
PCT/IT2000/000158 WO2000064426A2 (en)	1999-04-22	2000-04-19	Carnitine and inositol phosphate-containing composition useful as dietary supplement or drug

Publications (1)

Publication Number	Publication Date
IS5763A true IS5763A (is)	2000-12-08

Family

ID=11406708

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS5763A IS5763A (is)	1999-04-22	2000-12-08	Samsetning sem inniheldur karnitín og inósitól fosfat gagnleg sem næringafræðilegt bætiefni eða lyf

Country Status (26)

Country	Link
US (1)	US6565876B1 (is)
EP (1)	EP1119363B1 (is)
JP (1)	JP2002542282A (is)
KR (1)	KR20010053023A (is)
CN (1)	CN1359295A (is)
AR (1)	AR023391A1 (is)
AT (1)	ATE299370T1 (is)
AU (1)	AU776591B2 (is)
BR (1)	BR0006076A (is)
CA (1)	CA2335015C (is)
DE (1)	DE60021247T2 (is)
DK (1)	DK1119363T3 (is)
EE (1)	EE200000742A (is)
ES (1)	ES2243254T3 (is)
HU (1)	HU227357B1 (is)
IL (1)	IL140164A0 (is)
IS (1)	IS5763A (is)
IT (1)	IT1306133B1 (is)
NO (1)	NO20006429L (is)
PL (1)	PL197885B1 (is)
PT (1)	PT1119363E (is)
SI (1)	SI1119363T1 (is)
SK (1)	SK19322000A3 (is)
TN (1)	TNSN00083A1 (is)
TR (1)	TR200003737T1 (is)
WO (1)	WO2000064426A2 (is)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1316997B1 (it) *	2000-03-02	2003-05-26	Sigma Tau Healthscience Spa	Composizione per la prevenzione e/o il trattamento di vasculopatie,che comprende propionil l-carnitina e coenzima q10.
DE10032964B4 (de) *	2000-07-06	2017-10-12	Beiersdorf Ag	Verwendung von Kreatin in kosmetischen oder dermatologischen Zubereitungen
DE10129502A1 (de) *	2001-06-19	2003-01-09	Beiersdorf Ag	Verwendung von Carnitin und/oder einem oder mehreren Acyl-Carnitinen zur Herstellung von kosmetischen oder dermatologischen Zubereitungen zur Steigerung der Ceramidbiosynthese
US8173618B2 (en) *	2003-07-25	2012-05-08	University Of Massachusetts	Formulations for reducing neuronal degeneration
US20090169585A1 (en) *	2003-10-23	2009-07-02	Resveratrol Partners, Llc	Resveratrol-Containing Compositions And Their Use In Modulating Gene Product Concentration Or Activity
US20050232911A1 (en) *	2004-04-19	2005-10-20	Schreiber Brian D	Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid
WO2006102060A1 (en) *	2005-03-18	2006-09-28	Oxyplus, Inc.	Calcium salt of myo-inositol 1,6:2,3:4,5 tripyrophosphate as an allosteric effector of hemoglobin
ES2280136B1 (es) *	2006-02-17	2008-08-16	Universitat De Les Illes Balears	Asociacion a dosis fija de fitato y zinc.
JP5281268B2 (ja) *	2007-10-31	2013-09-04	花王株式会社	筋力向上剤
US8597640B2 (en) *	2007-10-31	2013-12-03	University Of Massachusetts Lowell	Over-the-counter vitamin/nutriceutical formulation that provides neuroprotection and maintains or improves cognitive performance in alzheimer's disease and normal aging
JP2012508267A (ja) *	2008-11-11	2012-04-05	シグマ−タウ・インドゥストリエ・ファルマチェウチケ・リウニテ・ソシエタ・ペル・アチオニ	セルライトの処置に有用な化合物
EP2582368B1 (en) *	2010-06-16	2018-05-09	Alfasigma S.p.A.	Acetyl-carnitine for use in a method for increasing neurogenesis in neural tissue
ES2495666B1 (es) *	2013-03-15	2015-08-10	Laboratoris Sanifit, S.L.	Uso de derivados con enlaces c-o-p en pacientes con fallo renal
KR102141971B1 (ko) *	2018-11-12	2020-08-06	주식회사 노암	항암용 조성물
TW202110437A (zh) *	2019-05-23	2021-03-16	美商希諾瓦有限責任公司	用於酒精誘發之皮膚潮紅之治療及緩解的組成物及方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5626849A (en) *	1995-06-07	1997-05-06	Reliv International, Inc.	Weight loss composition for burning and reducing synthesis of fats
EP1021177A4 (en) *	1997-02-04	2002-05-15	John V Kosbab	COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF VASCULAR DEGENERATIVE DISEASES
IT1291113B1 (it) *	1997-03-20	1998-12-29	Sigma Tau Ind Farmaceuti	Composizione nutritiva terapeutica per soggetti affetti da diabete mellito
US5904924A (en) *	1997-11-04	1999-05-18	Oncologics, Inc.	Green nutritional powder composition

1999
- 1999-04-22 IT IT1999RM000248A patent/IT1306133B1/it active
2000
- 2000-04-05 AR ARP000101562A patent/AR023391A1/es unknown
- 2000-04-19 TR TR2000/03737T patent/TR200003737T1/xx unknown
- 2000-04-19 JP JP2000613417A patent/JP2002542282A/ja active Pending
- 2000-04-19 SI SI200030711T patent/SI1119363T1/xx unknown
- 2000-04-19 EP EP00922866A patent/EP1119363B1/en not_active Expired - Lifetime
- 2000-04-19 WO PCT/IT2000/000158 patent/WO2000064426A2/en not_active Ceased
- 2000-04-19 HU HU0102926A patent/HU227357B1/hu not_active IP Right Cessation
- 2000-04-19 EE EEP200000742A patent/EE200000742A/xx unknown
- 2000-04-19 PT PT00922866T patent/PT1119363E/pt unknown
- 2000-04-19 DE DE60021247T patent/DE60021247T2/de not_active Expired - Lifetime
- 2000-04-19 DK DK00922866T patent/DK1119363T3/da active
- 2000-04-19 KR KR1020007014435A patent/KR20010053023A/ko not_active Withdrawn
- 2000-04-19 CA CA002335015A patent/CA2335015C/en not_active Expired - Lifetime
- 2000-04-19 PL PL346160A patent/PL197885B1/pl unknown
- 2000-04-19 SK SK1932-2000A patent/SK19322000A3/sk unknown
- 2000-04-19 AT AT00922866T patent/ATE299370T1/de active
- 2000-04-19 IL IL14016400A patent/IL140164A0/xx unknown
- 2000-04-19 BR BR0006076-3A patent/BR0006076A/pt not_active Application Discontinuation
- 2000-04-19 ES ES00922866T patent/ES2243254T3/es not_active Expired - Lifetime
- 2000-04-19 CN CN00800654A patent/CN1359295A/zh active Pending
- 2000-04-19 AU AU43135/00A patent/AU776591B2/en not_active Ceased
- 2000-04-19 US US09/720,099 patent/US6565876B1/en not_active Expired - Lifetime
- 2000-04-20 TN TNTNSN00083A patent/TNSN00083A1/fr unknown
- 2000-12-08 IS IS5763A patent/IS5763A/is unknown
- 2000-12-15 NO NO20006429A patent/NO20006429L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
US6565876B1 (en)	2003-05-20
AR023391A1 (es)	2002-09-04
SI1119363T1 (en)	2005-10-31
CA2335015A1 (en)	2000-11-02
NO20006429L (no)	2001-02-20
BR0006076A (pt)	2001-03-20
AU776591B2 (en)	2004-09-16
JP2002542282A (ja)	2002-12-10
ATE299370T1 (de)	2005-07-15
DE60021247T2 (de)	2006-04-27
PL197885B1 (pl)	2008-05-30
ES2243254T3 (es)	2005-12-01
HUP0102926A2 (hu)	2002-03-28
EE200000742A (et)	2002-04-15
IT1306133B1 (it)	2001-05-30
EP1119363A2 (en)	2001-08-01
HUP0102926A3 (en)	2002-12-28
SK19322000A3 (sk)	2001-06-11
ITRM990248A1 (it)	2000-10-22
KR20010053023A (ko)	2001-06-25
DE60021247D1 (de)	2005-08-18
NO20006429D0 (no)	2000-12-15
DK1119363T3 (da)	2005-10-17
AU4313500A (en)	2000-11-10
TNSN00083A1 (fr)	2005-11-10
EP1119363B1 (en)	2005-07-13
TR200003737T1 (tr)	2001-07-23
PT1119363E (pt)	2005-09-30
WO2000064426A2 (en)	2000-11-02
IL140164A0 (en)	2002-02-10
CN1359295A (zh)	2002-07-17
CA2335015C (en)	2008-03-18
PL346160A1 (en)	2002-01-28
WO2000064426A3 (en)	2001-05-25
HU227357B1 (en)	2011-04-28

Publication	Publication Date	Title
GB9916536D0 (en)	1999-09-15	Nutritional or pharmaceutical compositions
HUP0204372A3 (en)	2004-06-28	Pharmaceutical compositions providing enhanced drug concentrations
IL135177A0 (en)	2001-05-20	Amidocarboxylic acid derivatives and pharmaceutical compositions containing the same
HUP0203378A3 (en)	2004-07-28	Pharmaceutical compounds and pharmaceutical compositions containing them
IL147970A0 (en)	2002-09-12	Pharmaceutical compositions containing tripeptides
IS7304A (is)	2004-06-10	Tvívetnissetin pýrasólýlbensýlsúlfónamíð og lyf sem innihalda téð efnasambönd
IL150383A0 (en)	2002-12-01	Glyburide and pharmaceutical compositions containing the same
HUP0201826A3 (en)	2004-03-01	Use of creatine as a nutritional supplement
HUP0102926A3 (en)	2002-12-28	Carnitine and inositol phosphate-containing composition useful as dietary supplement or drug
HUP0102369A3 (en)	2002-05-28	Amino acid derivatives and drugs containing the same as the active ingredient
HUP0200747A3 (en)	2003-02-28	Pharmaceutical compounds and pharmaceutical compositions containing them
HUP0000042A3 (en)	2001-07-30	Omega-3-fatacid and vitamin containing meet product
HUP0200055A3 (en)	2002-10-28	16-hydroxyestrienes and pharmaceutical compositions containing the same
IL136612A (en)	2003-11-23	Phenylaminoalkyl-carboxylic acid derivatives and pharmaceutical compositions containing the same
GB9813031D0 (en)	1998-08-12	Dietary supplement
GB9820815D0 (en)	1998-11-18	Improvementsin or relating to nutritional and pharmaceutical compositions
GB9818927D0 (en)	1998-10-21	Pharmaceutical formulation
PL337807A1 (en)	2000-09-11	Sertralin dosage formulation in the form of a gelatine-encapsulated solution
IL138994A0 (en)	2001-11-25	2-methylpropionic acid derivatives and medicinal compositions containing the same
HUP0200812A3 (en)	2003-07-28	Vitamin d analogues and their pharmaceutical use
IL133851A0 (en)	2001-04-30	Dietary supplement
GB9822333D0 (en)	1998-12-09	Pharmaceutical formulation
GB9817470D0 (en)	1998-10-07	Pharmaceutical formulation
AP2002002402A0 (en)	2002-03-31	Streptogramin derivatives production thereof and compositions containing the same
HUP0500956A3 (en)	2013-01-28	Oxapenem-3-carboxylic acids and pharmaceutical compositions containing them